Medical Treatment for Urinary Tract Infections

James Ross; Duane Hickling

doi:10.1016/j.ucl.2021.12.004

Medical Treatment for Urinary Tract Infections

Urol Clin North Am. 2022 May;49(2):283-297. doi: 10.1016/j.ucl.2021.12.004. Epub 2022 Mar 23.

Authors

James Ross¹, Duane Hickling²

Affiliations

¹ Department of Surgery, Division of Urology, Functional and Reconstructive Urology, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario K1Y4E9, Canada.
² Department of Surgery, Division of Urology, Female Pelvic Medicine and Reconstructive Surgery, University of Ottawa, 1053 Carling Avenue, Ottawa, Ontario K1Y4E9, Canada. Electronic address: dhickling@toh.ca.

PMID: 35428434
DOI: 10.1016/j.ucl.2021.12.004

Abstract

Urinary tract infections (UTIs) are a common source of morbidity and require significant health care resources for diagnosis, treatment, and prevention. Antimicrobials represent the mainstay for the treatment of UTIs. Established guidelines exist for the antimicrobial treatment and prevention of uncomplicated UTIs; however, antimicrobial dependence and overuse have led to the emergence of antimicrobial resistance. Nonantimicrobial alternatives are an ongoing area of research and should be considered when clinically appropriate based on available evidence.

Keywords: Antimicrobials; Nonantimicrobial treatment; Prophylaxis; Urinary tract infection.

Publication types

Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents*
Female
Humans
Male
Urinary Tract Infections* / diagnosis
Urinary Tract Infections* / drug therapy
Urinary Tract Infections* / etiology

Substances

Anti-Bacterial Agents
Anti-Infective Agents